Vitrosens Biotechnology Inc.

Vitrosens Biotechnology Inc. is a high-tech company that specializes in developing rapid test systems and devices in the fields of clinical diagnostics, public health, and veterinary diagnostics. The company offers a range of tests including POCT and IFA tests for infectious diseases (SARS-CoV-2), drug of abuse, cardiac and hormone tests within the scope of clinical diagnostics. In the area of veterinary diagnostics, Vitrosens Biotechnology provides rapid tests, ELISA tests, qPCR tests for cattle/ovine, pet, and poultry diagnoses. Since its inception in 2020, the company has garnered attention with its response to the Covid-19 pandemic. Vitrosens Biotechnology has successfully delivered millions of Covid-19 SARS-CoV-2 Rapid Antigen and Antibody test kits to more than 40 countries worldwide under the RapidFor® brand. The company operates in the industries of Biotechnology, Health Care, and Manufacturing with its headquarters located in Turkey. While details about the latest investment and investors are not available at the moment, Vitrosens Biotechnology's innovative approach to rapid test development marks it as a promising player in the biotechnology and healthcare sectors.